Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ANIMAL PERFORMANCE ENHANCERS INDUSTRY
2.1 Summary about Animal Performance Enhancers Industry
2.2 Animal Performance Enhancers Market Trends
2.2.1 Animal Performance Enhancers Production & Consumption Trends
2.2.2 Animal Performance Enhancers Demand Structure Trends
2.3 Animal Performance Enhancers Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Antibiotic
4.2.2 Hormonal
4.2.3 Beta-Agonist
4.2.4 Feed Enzymes
4.2.5 Probiotics and Prebiotics
4.2.6 Organic Acid
4.2.7 Phytogenic
4.2.8 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Poultry
4.3.2 Porcine
4.3.3 Livestock
4.3.4 Equine
4.3.5 Aquaculture
4.3.6 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Antibiotic
5.2.2 Hormonal
5.2.3 Beta-Agonist
5.2.4 Feed Enzymes
5.2.5 Probiotics and Prebiotics
5.2.6 Organic Acid
5.2.7 Phytogenic
5.2.8 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Poultry
5.3.2 Porcine
5.3.3 Livestock
5.3.4 Equine
5.3.5 Aquaculture
5.3.6 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Antibiotic
6.2.2 Hormonal
6.2.3 Beta-Agonist
6.2.4 Feed Enzymes
6.2.5 Probiotics and Prebiotics
6.2.6 Organic Acid
6.2.7 Phytogenic
6.2.8 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Poultry
6.3.2 Porcine
6.3.3 Livestock
6.3.4 Equine
6.3.5 Aquaculture
6.3.6 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Antibiotic
7.2.2 Hormonal
7.2.3 Beta-Agonist
7.2.4 Feed Enzymes
7.2.5 Probiotics and Prebiotics
7.2.6 Organic Acid
7.2.7 Phytogenic
7.2.8 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Poultry
7.3.2 Porcine
7.3.3 Livestock
7.3.4 Equine
7.3.5 Aquaculture
7.3.6 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Antibiotic
8.2.2 Hormonal
8.2.3 Beta-Agonist
8.2.4 Feed Enzymes
8.2.5 Probiotics and Prebiotics
8.2.6 Organic Acid
8.2.7 Phytogenic
8.2.8 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Poultry
8.3.2 Porcine
8.3.3 Livestock
8.3.4 Equine
8.3.5 Aquaculture
8.3.6 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Antibiotic
9.2.2 Hormonal
9.2.3 Beta-Agonist
9.2.4 Feed Enzymes
9.2.5 Probiotics and Prebiotics
9.2.6 Organic Acid
9.2.7 Phytogenic
9.2.8 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Poultry
9.3.2 Porcine
9.3.3 Livestock
9.3.4 Equine
9.3.5 Aquaculture
9.3.6 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Cargill, Inc. (U.S.)
10.1.2 Royal DSM N.V. (Netherlands)
10.1.3 Zoetis, Inc. (U.S.)
10.1.4 AB Vista (U.K.)
10.1.5 Alltech, Inc. (U.S.)
10.1.6 Elanco Animal Health (U.S.)
10.1.7 Bayer Animal Health (Germany)
10.1.8 BIOMIN Holding GmbH (Austria)
10.1.9 Boehringer Inghelheim (Germany)
10.1.10 Bupo Animal Health (South Africa)
10.1.11 Chr. Hansen A/S (Denmark)
10.1.12 DuPont Nutrition & Health (U.S.)
10.1.13 Merck Animal Health (U.S.)
10.1.14 Novus International, Inc. (U.S.)
10.1.15 Vetoquinol (France)
10.2 Animal Performance Enhancers Sales Date of Major Players (2017-2020e)
10.2.1 Cargill, Inc. (U.S.)
10.2.2 Royal DSM N.V. (Netherlands)
10.2.3 Zoetis, Inc. (U.S.)
10.2.4 AB Vista (U.K.)
10.2.5 Alltech, Inc. (U.S.)
10.2.6 Elanco Animal Health (U.S.)
10.2.7 Bayer Animal Health (Germany)
10.2.8 BIOMIN Holding GmbH (Austria)
10.2.9 Boehringer Inghelheim (Germany)
10.2.10 Bupo Animal Health (South Africa)
10.2.11 Chr. Hansen A/S (Denmark)
10.2.12 DuPont Nutrition & Health (U.S.)
10.2.13 Merck Animal Health (U.S.)
10.2.14 Novus International, Inc. (U.S.)
10.2.15 Vetoquinol (France)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table Animal Performance Enhancers Product Type Overview
2.Table Animal Performance Enhancers Product Type Market Share List
3.Table Animal Performance Enhancers Product Type of Major Players
4.Table Brief Introduction of Cargill, Inc. (U.S.)
5.Table Brief Introduction of Royal DSM N.V. (Netherlands)
6.Table Brief Introduction of Zoetis, Inc. (U.S.)
7.Table Brief Introduction of AB Vista (U.K.)
8.Table Brief Introduction of Alltech, Inc. (U.S.)
9.Table Brief Introduction of Elanco Animal Health (U.S.)
10.Table Brief Introduction of Bayer Animal Health (Germany)
11.Table Brief Introduction of BIOMIN Holding GmbH (Austria)
12.Table Brief Introduction of Boehringer Inghelheim (Germany)
13.Table Brief Introduction of Bupo Animal Health (South Africa)
14.Table Brief Introduction of Chr. Hansen A/S (Denmark)
15.Table Brief Introduction of DuPont Nutrition & Health (U.S.)
16.Table Brief Introduction of Merck Animal Health (U.S.)
17.Table Brief Introduction of Novus International, Inc. (U.S.)
18.Table Brief Introduction of Vetoquinol (France)
19.Table Products & Services of Cargill, Inc. (U.S.)
20.Table Products & Services of Royal DSM N.V. (Netherlands)
21.Table Products & Services of Zoetis, Inc. (U.S.)
22.Table Products & Services of AB Vista (U.K.)
23.Table Products & Services of Alltech, Inc. (U.S.)
24.Table Products & Services of Elanco Animal Health (U.S.)
25.Table Products & Services of Bayer Animal Health (Germany)
26.Table Products & Services of BIOMIN Holding GmbH (Austria)
27.Table Products & Services of Boehringer Inghelheim (Germany)
28.Table Products & Services of Bupo Animal Health (South Africa)
29.Table Products & Services of Chr. Hansen A/S (Denmark)
30.Table Products & Services of DuPont Nutrition & Health (U.S.)
31.Table Products & Services of Merck Animal Health (U.S.)
32.Table Products & Services of Novus International, Inc. (U.S.)
33.Table Products & Services of Vetoquinol (France)
34.Table Market Distribution of Major Players
35.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
36.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
37.Table Global Animal Performance Enhancers Market Forecast (Million USD) by Region 2021f-2026f
38.Table Global Animal Performance Enhancers Market Forecast (Million USD) Share by Region 2021f-2026f
39.Table Global Animal Performance Enhancers Market Forecast (Million USD) by Demand 2021f-2026f
40.Table Global Animal Performance Enhancers Market Forecast (Million USD) Share by Demand 2021f-2026f